G210 InviCell Plus with SignipHy pH monitoring

K191020 · CooperSurgical, Inc. · PUB · Jan 14, 2020 · Obstetrics/Gynecology

Device Facts

Record IDK191020
Device NameG210 InviCell Plus with SignipHy pH monitoring
ApplicantCooperSurgical, Inc.
Product CodePUB · Obstetrics/Gynecology
Decision DateJan 14, 2020
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 884.6120
Device ClassClass 2

Intended Use

The G210 InviCell Plus with SignipHy™ pH Monitoring System is a bench-top incubator that is intended to provide a controlled environment at or near body temperature and gas levels (CO2, O2, and N2) for the development of gametes and/or embryos during In Vitro Fertilization (IVF) / Assisted Reproductive Technology (ART) treatments. The G210 InviCell Plus with SignipHy™ pH Monitoring System includes an accessory for pH monitoring of surrogate samples of bicarbonate-based culture media used for ART procedures.

Device Story

Bench-top incubator for IVF/ART; provides controlled temperature and gas environment (CO2, O2, N2) for gametes/embryos. Includes SignipHy™ pH Monitoring System: TrakPod (LED-based optical measurement instrument), sv2 Sensor (single-use polystyrene vessel with pH-sensitive dye membrane), TrakStation (tablet with proprietary software), and qc² Alignment Tool. TrakPod sends green light (518 nm) through fiber optic to sensor; dye membrane reflects light (600 nm) proportional to pH. TrakStation displays/stores pH data. Used in clinical labs by embryologists/technicians. pH monitoring provides environmental data to assist in maintaining culture conditions. Benefits include real-time pH tracking of surrogate media to ensure optimal development environment.

Clinical Evidence

No clinical data. Bench testing only. Includes sterilization validation (ISO 11135, AAMI TIR28), shelf-life/package integrity (ASTM F1886, F88, F1929), electrical safety (IEC 61010-2-010/101), EMC (IEC 61326-1), and software/cybersecurity validation. pH monitoring validation confirmed linearity, stability, precision, and accuracy. Light safety testing confirmed no toxicity. Mouse Embryo Assay (MEA) met specification (≥90% blastocysts at 96h) under worst-case operation.

Technological Characteristics

Bench-top incubator with 10 incubation chambers and 1 preparation chamber. Resistive heating foil. Gas supply: internally regulated CO2, O2, N2. pH monitoring: LED-based optical measurement (518 nm excitation, 600 nm emission). Materials: Polystyrene (sv2 sensor). Connectivity: USB (TrakPod to TrakStation). Sterilization: Ethylene oxide (sv2 sensor). Software: Minor level of concern.

Indications for Use

Indicated for use in IVF/ART treatments to provide a controlled environment (temperature, CO2, O2, N2) for gamete and embryo development, and to monitor pH of surrogate bicarbonate-based culture media samples.

Regulatory Classification

Identification

Assisted reproduction accessories are a group of devices used during assisted reproduction procedures, in conjunction with assisted reproduction needles and/or assisted reproduction catheters, to aspirate, incubate, infuse, and/or maintain temperature. This generic type of device may include:(1) Powered aspiration pumps used to provide low flow, intermittent vacuum for the aspiration of eggs (ova). (2) Syringe pumps (powered or manual) used to activate a syringe to infuse or aspirate small volumes of fluid during assisted reproduction procedures. (3) Collection tube warmers, used to maintain the temperature of egg (oocyte) collection tubes at or near body temperature. A dish/plate/microscope stage warmer is a device used to maintain the temperature of the egg (oocyte) during manipulation. (4) Embryo incubators, used to store and preserve gametes and/or embryos at or near body temperature. (5) Cryopreservation instrumentation and devices, used to contain, freeze, and maintain gametes and/or embryos at an appropriate freezing temperature.

Special Controls

*Classification.* Class II (special controls) (design specifications, labeling requirements, and clinical testing). The device, when it is a simple embryo incubator with only temperature, gas, and humidity control; a syringe pump; a collection tube warmer; a dish/plate/microscope stage warmer; a controlled-rate cryopreservation freezer; or an assisted reproduction laminar flow workstation is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 884.9.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue. January 14, 2020 CooperSurgical Inc. Kyle Hooper Regulatory Affairs Associate 95 Corporate Drive Trumbull, CT 06611 Re: K191020 Trade/Device Name: G210 InviCell Plus with SignipHyTM pH Monitoring System Regulation Number: 21 CFR 884.6120 Regulation Name: Assisted Reproduction Accessories Regulatory Class: II Product Code: PUB Dated: December 12, 2019 Received: December 13, 2019 Dear Kyle Hooper: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's {1}------------------------------------------------ requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems. For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100). Sincerely, Monica D. Garcia, Ph.D. Acting Assistant Director DHT3B: Division of Reproductive. Gynecology and Urology Devices OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ #### Indications for Use 510(k) Number (if known) K191020 Device Name G210 InviCell Plus with SignipHyTM pH Monitoring System Indications for Use (Describe) The G210 InviCell Plus with SignipHy™ pH Monitoring System is a bench-top incubator that is intended to provide a controlled environment at or near body temperature and gas levels (CO2, O2, and N2) for the development of gametes and/or embryos during In Vitro Fertilization (IVF) / Assisted Reproductive Technology (ART) treatments. The G210 InviCell Plus with SignipHy™ pH Monitoring System includes an accessory for pH monitoring of surrogate samples of bicarbonate-based culture media used for ART procedures. | Type of Use (Select one or both, as applicable) | | |-------------------------------------------------|---------------------------------------------------------------------------------------| | Prescription Use (Part 21 CFR 801 Subpart D) | <div> <span> ☑ </span> </div> | | Over-The-Counter Use (21 CFR 801 Subpart C) | <div> <span> ☐ </span> </div> | #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ Image /page/3/Picture/0 description: The image shows the logo for Cooper Surgical. The logo is in blue and consists of the words "Cooper Surgical" in a stylized font. Below the logo is the tagline "Healthy women, babies, and families" in a smaller font, also in blue. The logo is simple and professional, and the tagline conveys the company's mission. K191020 Page 1 of 7 # 510(k) Summary K191020 ### Submitter Information | Company Name: | CooperSurgical Inc. | |------------------|-------------------------------------------------------------------| | Company Address: | 95 Corporate Drive<br>Trumbull, CT 06611 USA | | Contact Person: | Kyle Hooper<br>Telephone: +1-203-601-5200<br>Fax: +1-203-601-9870 | January 13, 2020 ## Device Information Date Prepared: | Trade Name: | G210 InviCell Plus with SignipHy™ pH Monitoring System | |--------------------|--------------------------------------------------------| | Common Name: | Embryo Incubator with pH monitoring | | Regulation Number: | 21 CFR 884.6120 | | Regulation Name: | Assisted Reproduction Accessories | | Product Code: | PUB (Accessory, Assisted Reproduction, Exempt) | | Regulatory Class: | II | ## Predicate Device Information Trade Name: BT37 Incubator (510(k) number: K121566) Common Name: IVF Incubator Classification Name: Accessory, Assisted Reproduction (21 CFR 884.6120) Product Code: MQG The predicate device has not been subject to a design-related recall. ## Device Description The G210 InviCell Plus with SignipHy™ pH Monitoring System is an assisted reproduction incubator that includes an accessory pH monitoring feature. The incubator component of this device (G210 Invicell) is regulated under 21 CFR 884.6120, product code PBH (exempt). The incubator includes 10 incubation chambers and one larger preparation chamber that is used for the equilibration of plates/oil before use. The tri-gas incubator provides a controlled environment (temperature, CO2/O2/N2) for gametes and embryos in the incubation chambers. {4}------------------------------------------------ Image /page/4/Picture/1 description: The image shows the logo for CooperSurgical. The logo is in blue and consists of the words "CooperSurgical" in a stylized font. Below the logo is the tagline "Healthy women, babies, and families™" also in blue. The pH monitoring feature of the G210 InviCell Plus with SignipHy™ pH Monitoring System is controlled separately and does not impact the operation or incubator functions of the device. The SignipHy™ pH Monitoring System consists of the following components: - . SignipHy™ TrakPod – An LED-based, optical pH measurement instrument. The SignipHy TrakPod is physically supported within the chassis of the incubator and allows monitoring of one incubator chamber. It is a USB connected fluorescent measurement device with a fiber optic cable and fixture that connects to the SignipHy sv2 Sensor inside an incubator chamber. The SignipHy TrakPod and SignipHy sv² Sensor together detect the pH of a liquid sample. - . SignipHy™ sv2 Sensor – The SignipHy sv2 Sensor is a single-use, polystyrene, ethylene oxide sterilized vessel that is loaded with a sample of bicarbonate-buffered assisted reproduction technology (ART) media with a pH between 6.8 and 7.2 for pH tracking. The bottom of the sensor includes a membrane that is impregnated with a dye that is affected by the pH of the media sample. The sensor fits into the SignipHy TrakPod fiber optic fixture located in an incubation chamber. SignipHy sv2 Sensors can be used for measuring pH at one-minute intervals for three days or 30-minute intervals for seven days. - . SignipHy™TrakStation – A tablet computer running proprietary software that initiates pH readings, displays results, and stores pH measurement data over time. Up to eight SignipHy TrakPods can be connected to a single SignipHy TrakStation. - SignipHy™ qc² Alignment Tool - A fluorescent reference device for use in system alignment and quality control. To make a pH measurement, the SignipHy TrakPod sends green light flashes (peak 518 nm) through the fiber optic fixture. The dye in the membrane reacts by sending back flashes of light at a different wavelength (peak 600 nm). The SignipHy TrakPod reads this result and calculates the pH of the media sample that is then displayed on and stored in the SignipHy™TrakStation. # Indications for Use The G210 InviCell Plus with SignipHy™ pH Monitoring System is a bench-top incubator that is intended to provide a controlled environment at or near body temperature and gas levels (CO2, O2, and N2) for the development of gametes and/or embryos during In Vitro Fertilization (IVF) / Assisted Reproductive Technology (ART) treatments. The G210 InviCell Plus with SignipHy™ pH Monitoring System includes an accessory for pH monitoring of surrogate samples of bicarbonate-based culture media used for ART procedures. {5}------------------------------------------------ Table 1 provides a comparison of the indications for use and technological characteristics of the subject device and predicate device. | Attribute | Subject<br>G210 InviCell Plus with SignipHy™ pH Monitoring System | Predicate<br>BT37 Incubator | Discussion | |--------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 510(k) Number | K191020 | K121566 | Not Applicable | | Manufacturer | CooperSurgical, Inc. | Planer Plc | Not Applicable | | Indications for<br>Use | The G210 InviCell Plus with<br>SignipHy™ pH Monitoring System<br>is a bench-top incubator that is<br>intended to provide a controlled<br>environment at or near body<br>temperature and gas levels (CO2,<br>O2, and N2) for the development<br>of gametes and/or embryos<br>during In Vitro Fertilization (IVF) /<br>Assisted Reproductive<br>Technology (ART) treatments.<br>The G210 InviCell Plus with<br>SignipHy™ pH Monitoring System<br>includes an accessory for pH<br>monitoring of surrogate samples<br>of bicarbonate-based culture<br>media used for ART procedures. | The Planer BT37 Incubator is<br>intended to be used to provide<br>an environment with controlled<br>temperature at or near body<br>temperature, CO2, O2 and N2<br>gases, and elevated humidity for<br>the development of gametes and<br>embryos during in vitro<br>fertilization (IVF) / assisted<br>reproductive technology (ART)<br>treatments | Different:<br>The subject and predicate devices<br>are both indicated for<br>maintaining temperature and gas<br>concentrations sufficient to<br>support gametes and embryos.<br>The predicate device indication<br>also lists maintenance of<br>humidity within the chamber.<br>Lack of humidity control in the<br>subject device does impact the<br>overall intended use of the<br>device (maintaining environment<br>for ART procedures). FDA has<br>cleared humidified and non-<br>humidified ART incubators.<br>The subject device indications for<br>use also lists the ability of the<br>device to measure pH of<br>bicarbonate-based media within<br>the incubator. The pH<br>information is given to laboratory<br>personnel to provide additional<br>information on the<br>environmental conditions within<br>the incubator, as pH changes are<br>influenced by CO2 concentrations.<br>Although the predicate device<br>does not include a pH<br>measurement function, the<br>overall intended use of the<br>subject and predicate devices is<br>the same (i.e., providing a<br>controlled environment for<br>gamete and embryo<br>development in vitro). | | Attribute | Subject<br>G210 InviCell Plus with SignipHy™<br>pH Monitoring System | Predicate<br>BT37 Incubator | Discussion | | General Design | Bench-top incubator with 10<br>incubation chambers and one<br>preparation chamber | Bench-top incubator with 2<br>incubation chambers | Different: The subject device has<br>more incubation chambers and<br>an additional chamber to<br>equilibrate plates/oil before use.<br>This difference does not raise<br>different questions of safety and<br>effectiveness (S&E). | | Gas Supply<br>Type | Internally regulated mixture of<br>CO2, O2 and N2 | Premixed blend of 6% CO2, 5% O2,<br>89% N2 | Different: The subject and<br>predicate devices use different<br>mechanisms to control gas<br>concentrations in incubator<br>chambers. This difference does<br>not raise different S&E questions. | | Gas Supply<br>Pressure | 0.5-1.0 bar<br>(50 – 100 kPa) | 150 kPa +/- 15 kPa | Different: The subject and<br>predicate devices have different<br>gas supply pressures based on<br>the different gas supply/control<br>methods. This difference does<br>not raise different S&E questions. | | Gas flow rate<br>capability | 1 l/h CO2 & 5 l/h N2 | 0 mL/min to 450 ml/min. Normal<br>bleed set to 15 ml/min and purge<br>at 180 ml/min for 3 minutes.<br>Flows fully adjustable in 1 ml/min<br>increments | Different: The subject and<br>predicate devices have different<br>gas flow rates based on the<br>different gas supply/control<br>methods. This difference does<br>not raise different S&E questions. | | Gas flow rate<br>accuracy | CO2: 1.5 l/h<br>N2: 7 l/h | ±10% or ± 3% ml/min | Different: The flow rate accuracy<br>is different for the subject and<br>predicate devices that use<br>different gas supply types.<br>Differences in flow rate accuracy<br>do not raise different questions<br>of S&E. | | Gas flow<br>pattern | Constant | Pulsed or non-pulsed (constant)<br>flow pattern. | Different: The subject device<br>does not include a pulsed flow<br>mode. This difference does not<br>raise different S&E questions. | | Incubation<br>Chamber<br>Heating | Resistive heating foil - bottom,<br>sides and lid of each chamber | Not known | Different: The heating<br>mechanism used in the predicate<br>device is not known. However,<br>differences in heating methods<br>do not raise different S&E<br>questions. | | Chamber<br>temperature<br>capability | Ambient to 42.9 °C | 5 °C above ambient to 40 °C | Similar | | Chamber<br>temperature<br>accuracy | ± 0.2 °C calibration point | ± 0.2 °C calibration point | Same | | Attribute | Subject<br>G210 InviCell Plus with SignipHy™<br>pH Monitoring System | Predicate<br>BT37 Incubator | Discussion | | Humidification<br>system | No | Yes | Different: The subject device<br>does not include a humidification<br>feature. This difference does not<br>raise different S&E questions.<br>FDA has cleared both humidified<br>and non-humidified ART<br>incubators. | | pH<br>Measurement<br>Function | Device includes a pH<br>measurement system that<br>includes a non-contact fiber optic<br>pH probe and sensor that holds a<br>representative media within one<br>incubation chamber, while a<br>separate display showing pH<br>information is on the exterior of<br>the incubator. | No | Different: The predicate device<br>does not include a pH<br>measurement system. The<br>inclusion of the pH system in one<br>incubation chamber provides<br>additional information on the<br>incubation environment. This<br>difference does not raise<br>different questions of S&E as<br>compared to the predicate (e.g.,<br>the ability to aid in maintaining<br>an appropriate culture<br>environment, materials do not<br>raise potential embryotoxicity<br>concerns, etc.). | Table 1: Subject and Predicate Device Comparison {6}------------------------------------------------ Image /page/6/Picture/0 description: The image contains the logo for CooperSurgical. The logo is written in a blue sans-serif font. The word "Cooper" is connected by a line underneath the word. Healthy women, babies, and families™ {7}------------------------------------------------ Image /page/7/Picture/0 description: The image shows the logo for CooperSurgical. The logo is written in a blue sans-serif font. The word "Cooper" is connected to the word "Surgical". Healthy women h As shown in the table above, the subject and predicate devices have different indications for use statements; however, the intended uses of the predicate and subject devices are the same (i.e., providing a controlled environment for gamete and embryo development in vitro during assisted reproduction technology procedures). In regards to technological characteristics, the subject and predicate devices have similarities (e.g., more than one incubation chamber, chamber temperature accuracy, etc.); however, as noted in the table above, technological differences were identified between the subject and predicate devices (e.g., pH monitoring system, gas supply, gas management, total number of incubation chambers, humidification of chambers, etc.). As stated in the table, the technological differences between the subject and predicate devices do not raise different questions of safety and effectiveness. #### Non-Clinical Performance Testing The following performance data were provided in support of the substantial equivalence determination: {8}------------------------------------------------ Healthy women, babies, and families™ - Sterilization Validation of SignipHy™ sv2 Sensors: ● - o ISO 11135:2014 Sterilization of health-care products -- Ethylene oxide --Requirements for the development, validation and routine control of a sterilization process for medical devices - AAMI TIR28:2016 Product Adoption and Process Equivalence for Ethylene Oxide o Sterilization - Residual testing was not conducted, as the sensor is non-patient and nono gamete/embryo contacting. - Shelf-Life of SignipHy™ sv2 Sensors: ● - o Package integrity testing at the end of shelf-life in real-time aged samples after shipping/distribution: - Visual Inspection per ASTM F1886/F1886M-16 . - . Seal Strength per ASTM F88/F88M-15 - I Dye penetration per ASTM F1929-15 - o SignipHy™ sv2 Sensor Performance at the end of shelf-life in real-time aged samples after shipping/distribution: - Comparison of subject device pH measurements to gold standard (blood gas analyzer) at a single time point. - I Assessment of pH under worst-case conditions (samples collected at one minute intervals for three days) as compared to gold standard (blood gas analyzer). - Reprocessing: Cleaning and disinfection validation testing conducted in accordance with ● the FDA guidance document, "Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling." - Electrical Safety, Electromagnetic Compatibility (EMC), and Wireless Technology: - o Electrical Safety Testing: - IEC 61010 2-010: 2014 (Third Edition) - . IEC 61010-2-101: 2015 (Second Edition) - o EMC Testing: - = IEC 61326-1:2012 - Wireless Technology: Information provided in accordance with the FDA o guidance document, "Radio Frequency Wireless Technology in Medical Devices. - Software and Cybersecurity: ● - o Software documentation in accordance with FDA guidance document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" to support device software with a minor level of concern. - Cybersecurity information in accordance with FDA guidance document "Content o of Premarket Submissions for Management of Cybersecurity in Medical Devices." {9}------------------------------------------------ Image /page/9/Picture/1 description: The image shows the logo for CooperSurgical. The logo is in blue and features the company name in a modern, sans-serif font. Below the company name is the tagline "Healthy women, babies, and families" also in blue. - pH Monitoring Validation Testing: ● - o The submission included testing to support the ability of the device to measure pH in bicarbonate-based ART media. Testing showed that the device met all specifications for each parameter assessed below: - I Linearity - l Stability - Precision - Accuracy - Interfering substances - Light Safety: Light energy exposure testing was performed to assess the potential for light toxicity associated with pH measurements taken under worst-case exposure conditions (samples taken every minute – total light exposure of 8.8 seconds/day). The results showed that the light wavelengths and worst-case light energy exposure duration did not raise safety concerns as compared to conventional imaging using standard laboratory ART imaging procedures. - Mouse Embryo Assay (MEA): Testing was performed to assess the impact of the device ● (SignipHy TrakPod and SignipHy sv2 Sensor) when in operation under worst-case conditions (samples taken every minute for 96h). The results of testing met the acceptance specification of "1-Cell MEA: ≥90% blastocysts at 96h." - Incubator Performance Testing: The incubator component of this device is 510(k) exempt and remains unchanged from that currently marketed. The additional pH monitoring system is separate from the incubator and does not impact its function. Therefore, performance testing on the incubator was not requested. #### Conclusion The results of the testing described above demonstrate that the subject G210 InviCell Plus with SignipHy™ pH Monitoring System is substantially equivalent to the predicate device.
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%